Diamyd Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is September - August.

Millions SEK. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Net Income	-182.46	-169.78	-151.85	-116.07	-103.52	60.05
Depreciation & Amortization	6.77	6.5	5.58	4.87	4.38	0.78
Asset Writedown & Restructuring Costs	-	-	5.41	-	-	-
Other Operating Activities	1.58	-5.53	3.77	1.69	-11.61	-145.64
Change in Accounts Receivable	-0.04	0.02	0.04	0.07	10.1	-19.57
Change in Accounts Payable	2.7	-4.64	11.72	-	-	-
Change in Other Net Operating Assets	-0.1	3.74	-3.85	-1.51	7.43	-5.1
Operating Cash Flow	-171.56	-169.68	-129.18	-110.96	-93.22	-109.47
Capital Expenditures	-8.03	-10.05	-8.03	-11.44	-34.65	-4.23
Investment in Securities	-18.97	27.22	-19.97	39.84	-39.91	-7.66
Other Investing Activities	0	-	-0	-	6.65	144.41
Investing Cash Flow	-27	17.17	-27.99	28.4	-76.72	132.53
Issuance of Common Stock	267.38	315.39	135.21	75.27	150	60
Other Financing Activities	-10.12	0.93	7.08	11.27	-7.85	-3.28
Financing Cash Flow	257.26	316.32	142.28	86.54	142.16	56.72
Foreign Exchange Rate Adjustments	1.76	0.62	0.12	3.79	8.17	1.22
Miscellaneous Cash Flow Adjustments	-	-	-	-	-	-0
Net Cash Flow	60.46	164.43	-14.78	7.77	-19.62	81.01
Free Cash Flow	-179.59	-179.73	-137.21	-122.4	-127.87	-113.69
Free Cash Flow Margin	-51458.74%	-138254.61%	-105543.08%	-22418.32%	-28165.42%	-44937.94%
Free Cash Flow Per Share	-1.48	-1.60	-1.45	-1.56	-1.67	-1.63
Cash Interest Paid	2.64	2.63	0.01	0	0.25	0.07
Levered Free Cash Flow	-117.02	-119.05	-87.83	-80.42	-82.04	-82.18
Unlevered Free Cash Flow	-117.02	-119.05	-87.82	-80.42	-81.88	-81.9
Change in Working Capital	2.56	-0.88	7.91	-1.45	17.52	-24.66

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.